Blood Pressure Control in Outpatients With Hypertension After the Publication of the JSH2000 Guidelines

Japanese Journal of Clinical Pharmacology and Therapeutics

Volumn 34, Issue 5, 2003, Pages 283-288

  Osuga, Emiko ^a   Tamachi, Hiromitsu ^a   Hayakawa, Hirokazu ^a  

^a Showa University Karasuyama Hospital   (Japan)

Author keywords

Antihypertensive therapy; Guidelines; Hypertension; Target blood pressure

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG CHOICE; DRUG INDICATION; FEMALE; HUMAN; HYPERTENSION; JAPAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRACTICE GUIDELINE; PRESCRIPTION; PROTEINURIA; PUBLICATION; SYSTOLIC BLOOD PRESSURE;

EID: 0142023912     PISSN: 03881601     EISSN: None     Source Type: Journal    
DOI: 10.3999/jscpt.34.5_283     Document Type: Article

References (18)

1. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-46.
2. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151-83.
3. Saito I, Kawabe H, Tsujioka M, Hirose H, Shibata H. Trends in pharmacologic management of hypertension in Japan one year after the publication of the JSH2000 guidelines. Hypertens Res 2002; 25: 175-8.
4. Muratani H, Fukiyama K, Kamiyama T, et al. Current status of antihypertensive therapy for elderly patients in Japan. Hypertens Res 1996; 19: 281-90.
5. Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Roccella EJ, Levy D. Differential control of systolic and diastolic blood pressure. Factors associated with lack of blood pressure control in the community. Hypertension 2000; 36: 594-9.
6. Iseki K, Iseki C, Ikemiya Y, Fukiyama K. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 1996; 49: 800-5.
7. Kannel WB. Fifty years of Framingham study contributions to understanding hypertension. J Hum Hypertens 2000; 14: 83-90.
8. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, Ménard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet 1998; 351: 1755-62.
9. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998; 317: 703-13.
10. Katayama S, Inaba M, Morita T, Awata T, Shimamoto K, Kikkawa R. Blood pressure control in Japanese hypertensives with or without type 2 diabetes mellitus. Hypertens Res 2000; 28: 601-5.
11. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brangati FL, Ford CE, Shulman NB, Stamler J. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13-8.
12. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 1995; 123: 754-62.
13. Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J. Preserving renal function in adults with hypertension and diabetes: a consensus approach. Am J Kidney Dis 2000; 36: 646-61.